ÂÜÀòÂÒÂ×

Harry Rose is a Research Engineer at Isomorphic Labs, a subsidiary of Alphabet focused on transforming drug discovery through AI. Prior to this role, Harry served as an AI Research Scientist at BenevolentAI, specializing in language models for clinical data. Earlier experience includes a position as a Synthetic Financing Trader at J.P. Morgan, dealing with equity total return swaps and single stock futures, along with a summer analyst role in the markets division at the same firm. Harry's educational background includes a Master's degree in Computational Statistics and Machine Learning from UCL and a BSc in Mathematics from the University of Warwick. Additionally, Harry participated in the GoGlobal Programme with AIESEC as a voluntary English teacher.